Arcus Biosciences (RCUS) Chief Medical Officer Move to Gilead (GILD) Suggests Strengthened Relationship Between the Companies - Mizuho

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. ARX

Go back to Arcus Biosciences (RCUS) Chief Medical Officer Move to Gilead (GILD) Suggests Strengthened Relationship Between the Companies - Mizuho

Arcus Biosciences (RCUS) Chief Medical Officer Grossman to Leave for Gilead (GILD)

July 19, 2021 5:10 PM EDT

Arcus Biosciences (NYSE: RCUS) announced that Bill Grossman M.D., Ph.D., will transition out of his role as chief medical officer at Arcus Biosciences and into a role at Gilead Sciences (NASDAQ: GILD) as senior vice president of oncology clinical research to oversee Gileads clinical-stage oncology portfolio. This will include leading Gileads efforts in the companys alliance with Arcus to co-develop and co-commercialize... More